Health Care & Life Sciences » Biotechnology | Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
14,219.00
9,757.00
1,253.00
5,421.00
154,584.00
301,034
Cost of Goods Sold (COGS) incl. D&A
-
-
-
5,741.00
8,406.00
35,058
Gross Income
-
-
-
320.00
146,178.00
265,976
SG&A Expense
101,926.00
139,742.00
207,008.00
261,848.00
282,832.00
607,926
EBIT
88,984.00
133,675.00
211,002.00
262,168.00
136,654.00
341,950
Unusual Expense
23,327.00
2,793.00
9,182.00
4,562.00
90,016.00
4,000
Non Operating Income/Expense
200.00
679.00
-
-
1,982.00
1,666
Interest Expense
-
-
-
535.00
5,781.00
33,709
Pretax Income
111,985.00
135,789.00
220,030.00
267,265.00
48,628.00
362,610
Income Tax
-
-
-
-
2,060.00
692
Consolidated Net Income
111,985.00
135,789.00
220,030.00
267,265.00
50,688.00
361,918
Net Income
111,985.00
135,789.00
220,030.00
267,265.00
50,688.00
361,918
Net Income After Extraordinaries
111,985.00
135,789.00
220,030.00
267,265.00
50,688.00
361,918
Net Income Available to Common
111,985.00
135,789.00
220,030.00
267,265.00
50,688.00
361,918
EPS (Basic)
3.31
3.39
5.20
5.49
0.86
5.46
Basic Shares Outstanding
33,850.00
40,026.00
42,290.00
48,697.00
58,818.00
66,250
EPS (Diluted)
3.31
3.39
5.20
5.49
0.86
5.46
Diluted Shares Outstanding
33,850.00
40,026.00
42,290.00
48,697.00
58,818.00
66,250
EBITDA
87,707.00
129,985.00
205,755.00
256,557.00
128,562.00
329,705
Non-Operating Interest Income
126.00
-
154.00
-
1,809.00
15,383

About Sarepta Therapeutics

View Profile
Address
215 First Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.sareptatherapeutics.com
Updated 07/08/2019
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases. It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.